Chemotherapy for Gastrointestinal Stromal Tumor

Chemotherapy (chemo) is the use of drugs to treat cancer. Often, these drugs are injected into a vein (IV) or given by mouth. They enter the bloodstream and reach throughout the body, making this treatment potentially useful for cancers that have spread beyond the organ they started in.

Any drug used to treat cancer can be considered chemo – even the targeted therapy drugs like imatinib (Gleevec) that are now commonly used to treat gastrointestinal stromal tumors (GISTs). But the term chemo is usually used to describe certain drugs that work by attacking quickly growing cells anywhere in the body, which includes cancer cells.

Before targeted therapy drugs were found to be helpful in treating GISTs, traditional chemo drugs were often tried. But GISTs rarely shrank in response to these drugs, so traditional chemo is rarely used today. Patients considering chemo may want to consider taking part in a clinical trial.

Possible side effects

Chemo drugs can cause side effects. These depend on the specific drugs used, their doses, and how long treatment lasts. Common side effects of chemo include:

  • Nausea and vomiting
  • Loss of appetite
  • Mouth sores
  • Diarrhea
  • Hair loss
  • An increased chance of infection (from a shortage of white blood cells)
  • Problems with bleeding or bruising (from a shortage of blood platelets)
  • Fatigue or shortness of breath (from low red blood cell counts)

Along with the risks above, some chemo drugs can cause other side effects.

Ask your health care team about what side effects you can expect based on the specific drugs you will get. Be sure to tell your doctor or nurse if you do have side effects, as there are often ways to help with them. For example, drugs can be given to help prevent or reduce nausea and vomiting.

To learn more, see Chemotherapy.

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master’s-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Casali PG, Dei Tos AP, Gronchi A. Chapter 55: Gastrointestinal Stromal Tumor. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

National Cancer Institute. Physician Data Query (PDQ). Gastrointestinal Stromal Tumors Treatment. 2017. Accessed at www.cancer.gov/types/soft-tissue-sarcoma/hp/gist-treatment-pdq on April 17, 2017.

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. V.2.2017. Accessed at  www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf on April 17, 2017.

Last Medical Review: May 17, 2017 Last Revised: May 17, 2017

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.